^
Association details:
| Biomarker: | CTAG1A expression |
|---|---|
| Cancer: | Gastroesophageal Cancer |
| Drug Class: | Immunotherapy |
| Direction: | Sensitive |
Evidence:
Source:
Title:
1427P - Cancer/testis antigen expression landscape in gastroesophageal adenocarcinoma
Published date:
09/13/2021
Excerpt:
NY-ESO-1 expression was associated with improved progression-free survival (PFS)(p=0.034) and OS (p=0.024) in immune checkpoint inhibitor-treated patients (n=23).
